The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 14, 2025
Filed:
Mar. 27, 2019
Inserm (Institut National DE LA Santé ET DE LA Recherche Médicale), Paris, FR;
Centre Hospitalier Regional ET Universitaire DE Brest, Brest, FR;
Université DE Bretagne Occidentale, Brest, FR;
Institut National DE Recherche Pour L'agriculture, L'alimentation ET L'environnement, Paris, FR;
Etablissement Français Du Sang (Efs), La Plaine Saint Denis, FR;
Geneviève Hery-Arnaud, Brest, FR;
Jérôme Mounier, Plouzané, FR;
Charles-Antoine Guilloux, Brest, FR;
Patricia Lepage, Jouy-en-Josas, FR;
Stanislas Mondot, Jouy-en-Josas, FR;
Marlène Keravec, Plouzané, FR;
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, Paris, FR;
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE BREST, Brest, FR;
UNIVERSITE BRETAGNE OCCIDENTALE, Brest, FR;
INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNMENT, Paris, FR;
ETABLISSEMENT FRANCAIS DU SANG (EFS), La Plaine Saint Denis, FR;
Abstract
The present invention relates to methods for predicting the risk of developing pulmonary colonization/infection by. The inventors analyzed the respiratory tract microbiota from 65 patients sputum samples and compared microbiota data. The inventors found that patients that will remain uninfected fromexhibited 3-fold higher abundance ofcompared to the other groups. In particular, the present invention relates to a method for predicting the risk of developing pulmonary colonization/infection byin a subject suffering from cystic fibrosis (CF) comprising measuring the abundance ofin a biological sample obtained from said subject.